Millennium Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Millennium Management's CDLX Position: Q1 2026 in Review
Millennium Management reduced its Cardlytics (CDLX) stake by 74% in Q1 2026, selling an estimated $185K and leaving 6,556 shares worth $68.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5394.
Millennium Management first reported a position in CDLX in Q1 2018 and has held it in 26 quarters since. The position peaked at $6.29M in Q3 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Millennium Management held 6,556 shares of Cardlytics worth $68.8K as of Q1 2026.
- Millennium Management sold 18,918 Cardlytics shares in Q1 2026, an estimated $185K.
- Cardlytics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5394 holding.
- Millennium Management first reported a position in Cardlytics in Q1 2018 and has held it in 26 quarters since.
- Millennium Management's Cardlytics position peaked at $6.29M in Q3 2019.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.